JAZZ PHARMACEUTICALS PLC
COM · CUSIP 472147107
1
institutional holders
+0 vs Q1 2023
120
shares reported held*
$14.9kreported value*
1 new
0 added
0 reduced
1 sold out
net sold ≈ $171.1k (-1.4k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $123.97.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2022 | 1 |
| Q1 2023 | 1 |
| Q2 2023 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2023 | 0 | 0 |
| Q2 2023 | 1 | 1 |
Biggest buyers
| Firsthand Capital Management, Inc. | New | +120 |
Biggest sellers
| Lattice Capital Management, LLC | Sold out | -1.5k |
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| Firsthand Capital Management, Inc. 0.02% of their portfolio | 120 $14.9k | New |